Screener
Protagonist Therapeutics PTGX Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Protagonist Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091123
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Deferred revenue | 9,659 | 9,550 |
| Operating lease liability | 2,396 | 2,283 |
| Total current liabilities | 37,181 | 45,441 |
| Operating lease liability - noncurrent | 6,820 | 8,040 |
| Total liabilities | 44,001 | 53,481 |
| Commitments and contingencies | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.00001 par value, 10,000,000 shares authorized; no shares issued and outstanding | — | — |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Protagonist Therapeutics's operating lease liabilities?
- Protagonist Therapeutics (PTGX) reported operating lease liabilities of $6.82M in Q2 2026.
- How has Protagonist Therapeutics's operating lease liabilities changed year-over-year?
- Protagonist Therapeutics's operating lease liabilities decreased by 25.1% year-over-year, from $9.11M to $6.82M.
- What is the long-term trend for Protagonist Therapeutics's operating lease liabilities?
- Over 4 years (2020 to 2025), Protagonist Therapeutics's operating lease liabilities has grown at a 15.6% compound annual growth rate (CAGR), from $4.5M to $8.04M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Protagonist Therapeutics's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude